Nonobviousness of Pharmaceutical Inventions: Implications for Patent Prosecution and Litigation
Pharmaceutical Patent Analyst · 2019-07 · 8 (4) · 91-107
DOI: 10.4155/ppa-2019-0014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Patent Analyst, online erschienen am 15.08.2019. Verfasst von Sivakami Dhulap und 1 weiteren Autor:innen. Beteiligte Einrichtung: CSIR-Unit for Research & Development of Information Products, 'Tapovan' S. no. 113 & 114, NCL Estate, Pashan Road, Pune, Maharashtra 411008, India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CSIR-Unit for Research & Development of Information Products, 'Tapovan' S. no. 113 & 114, NCL Estate, Pashan Road, Pune, Maharashtra 411008, India.
- Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India.
Zitieren
APA
Dhulap, S., & Kulkarni, M. (2019). Nonobviousness of Pharmaceutical Inventions: Implications for Patent Prosecution and Litigation. Pharmaceutical Patent Analyst, 8(4), 91-107. https://doi.org/10.4155/ppa-2019-0014
Vancouver
Dhulap S, Kulkarni M. Nonobviousness of Pharmaceutical Inventions: Implications for Patent Prosecution and Litigation. Pharmaceutical Patent Analyst. 2019;8(4):91-107. doi:10.4155/ppa-2019-0014
BibTeX
@article{Dhulap2019,
author = {Dhulap, Sivakami and Kulkarni, Mohan},
title = {Nonobviousness of Pharmaceutical Inventions: Implications for Patent Prosecution and Litigation},
journal = {Pharmaceutical Patent Analyst},
year = {2019},
volume = {8},
number = {4},
pages = {91--107},
doi = {10.4155/ppa-2019-0014}
}
EUVIMED